Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

CAMK2A T1172-p
Fyn Y877-p
HER2 Y877-p , Y1196-p , Y1222-p
PKACA T686-p
PKCA T686-p
PKG2 T686-p
Src Y877-p
Yes Y877-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

AMPKA1 T900-p
CAMK2A T1172-p
ERK1 T701-p
ERK2 T701-p
HER2 Y1023-p , Y1112-p , Y1139-p , Y1221-p , Y1222-p , Y1248-p
PKACA T686-p
PKCA T686-p
Src Y877-p
Phosphatases, in vitro:
ACPP Y877-p , Y1221-p , Y1222-p , Y1248-p
PTP-PEST Y1112-p , Y1196-p , Y1248-p
PTPRO Y1248-p
Regulatory protein:
AMPKA1 Y1196-p , Y1248-p
BTG2 Y1221-p , Y1222-p
CDCP1 Y1248-p
EGF Y1248-p
HER2 Y1248-p
HRas Y1221-p , Y1222-p
MUC4 Y1139-p , Y1248-p
PIK3CA Y1248-p
PKG2 Y1248-p
Src Y1248-p
Treatment:
2-deoxyglucose Y877-p
3-aminobenzamide Y1248-p
4-HT Y1248-p
8pCPT-cGMP T686-p , Y1248-p
acadesine Y1221-p , Y1222-p , Y1248-p
adenosine T686-p , Y1248-p
adriamycin T701-p
AEE788 Y877-p , Y1221-p , Y1222-p
anti-HER2 Y877-p , Y1221-p , Y1222-p , Y1248-p
beta-amyloid Y1221-p , Y1222-p , Y1248-p
bpV Y1248-p
calcitonin Y1221-p , Y1222-p , Y1248-p
cAMP_analog Y1248-p
canertinib Y1248-p
cisplatin T701-p
colforsin T686-p , Y877-p , Y1221-p , Y1222-p , Y1248-p
EGF Y877-p , S1054-p , T1166-p , T1172-p , Y1221-p , Y1222-p , Y1248-p
erlotinib Y877-p , Y1005-p , Y1023-p , Y1112-p , Y1221-p , Y1222-p , Y1248-p
estradiol Y877-p , Y1248-p
FGF2 Y877-p
gefitinib Y1112-p , Y1127-p , Y1221-p , Y1222-p , Y1248-p
geldanamycin Y1248-p
H-89 Y1248-p
Herceptin/rGel Y877-p , Y1221-p , Y1222-p
heregulin Y877-p , Y1023-p , Y1196-p , Y1221-p , Y1222-p , Y1248-p
HGF Y1248-p
IGF-1 Y1248-p
ischemia T701-p , S998-p , S1054-p , S1078-p , S1083-p , S1174-p , T1240-p
isoproterenol T686-p , Y1248-p
lapatinib Y877-p , S998-p , S1050-p , S1051-p , T1052-p , S1054-p , S1083-p , S1107-p , Y1221-p , Y1222-p , Y1248-p
leptin Y1248-p
LY294002 Y1196-p , Y1221-p , Y1222-p
metastatic potential S1054-p
neuregulin Y877-p , Y1221-p , Y1222-p , Y1248-p
nocodazole S1107-p
PD168393 Y877-p
PDGF Y1222-p
peptide inhibitor Y1248-p
pertuzumab Y877-p
phorbol_ester T686-p , T701-p , Y1196-p , Y1222-p , Y1248-p
PKI166 Y1196-p
PP1 Y877-p , Y1248-p
PP2 Y1196-p , Y1221-p , Y1222-p
PP3 Y1196-p , Y1221-p , Y1222-p
racepinefrine T686-p , Y1248-p
SB203580 Y1196-p , Y1221-p , Y1222-p
SCH772984 T701-p
selumetinib T701-p , S1054-p
Su11274 Y1248-p
tamoxifen Y877-p
TGF-alpha Y877-p , Y1023-p
thapsigargin T1172-p
tPA T701-p
Trametinib T701-p , Y1196-p , Y1248-p
U0126 T701-p , Y1196-p , Y1221-p , Y1222-p , Y1248-p
U73122 Y1196-p , Y1221-p , Y1222-p
vanadate T686-p
vemurafenib T701-p , S1054-p